PHAST is a thought leader in the Public Health field. Here you can find up to date commentary and the latest updates in the sector.
Gilead Sciences Ltd commissioned PHAST to undertake some research to inform the next steps in NASH and NAFLD Service Delivery. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each...Read more
A message on behalf of Barbara Carter-Szatynska
Health Survey for England
Our annual HSE seminar will take place this year on Thursday 23rd May, 2-5pm, at UCL, B17 Lecture Theatre, 1-19 Torrington Place, London WC1E 7HB.
The survey series covers...Read more
Over the course of 2018, FPH has been making the case for increased investment in public health services and prevention across local government and the NHS.
We see five main arguments for investing in public health and prevention:
- It will improve the health and wellbeing of ...Read more
PHE, in partnership with Cancer Research UK, have published new data showing how chemotherapy, radiotherapy and surgery rates vary for different groups of patients in England.
PHAST is 10 years old !!
PHAST was created as a Community Interest Company on January 22nd 2008.
So a big Thank You to our Associates and Clients who have supported us through a wonderful decade of interesting projects and educational training events.
We start this year...Read more
We held a Friends and Associates meeting last week and had two very interesting presentations and an informative talk. The slides are available to download below.
Dr Eva Hrobonova spoke about an impressive programme she is managing in North West London called...Read more